Emerging Markets Collaborate to Succeed in Post-Pandemic World
Apr 11, 202318m0
Hosted on Acast. See acast.com/privacy for more information.
Loading…
Loading…
Hosted by Genetic Engineering and Biotechnology News · 🇺🇸 US · EN · 70 episodes
Established thought leaders with verified media credentials.
Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition monthly and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN's unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, and commercialization.GEN's print magazine, which also can easily be accessed online, includes feature articles on emerging technologies, product roundups, in-depth overviews from key scientific and bioindustry meetings, and industry-standard tutorials and technical articles on drug discovery, bioprocessing, and assay technologies. Hosted on Acast. See acast.com/privacy for more information.
Genetic Engineering and Biotechnology News hosts GEN Podcasts, a science show with 70 episodes published.
Hosted on Acast. See acast.com/privacy for more information.
As good scientific investigators, we strive to make our research more reproducible, repeatable, and translatable. These traits are ostensibly engrained in researchers from the start of their careers but often fall to the
Single-use systems have been steadily climbing toward the top of the tools utilized by biomanufacturers for the commercial-scale production of critical therapeutic products. However, COVID-19 created an inflection point
The demand for safe and efficacious biologics has accelerated exponentially in the past several years due to the tremendous success of some of the initial therapeutic offerings in this space. Yet, along with this increas
The success and applications of cell and gene therapies are seemingly limitless, and economic forecasts project a compound annual growth rate of almost 40% over the next eight years. This rapid expansion is a double edge
This is the final episode in our three-part GENcast series, where we discuss the virtues of mechanistic modeling and how it can significantly impact critical decision-making points in the drug discovery process, especial
This is part two in our three-part GENcast series, where we discuss various aspects of the drug discovery and development process and, in particular, how advanced computational techniques like mechanistic modeling can he
The drug discovery and development process can be an arduous endeavor. Manufacturers spend considerable resources and money chasing down potential candidate molecules to create a potential new therapeutic—often resulting
GEN Biotechnology is the new peer-reviewed journal launching in early 2022 by Mary Ann Liebert Inc. aiming to publish outstanding original research and perspectives across the biotech field. In this Q&A, GEN Biotechnolog
Hosted on Acast. See acast.com/privacy for more information.
Navigating the Regulatory Terrain during Cell & Gene Therapy Production by Genetic Engineering and Biotechnology News Hosted on Acast. See acast.com/privacy for more information.
Solve Your Biotherapeutic Challenges with Help from Gene Therapy University by Genetic Engineering and Biotechnology News Hosted on Acast. See acast.com/privacy for more information.
Engineered Therapy: Ramping Up CAR-T Biomanufacturing Goals by Genetic Engineering and Biotechnology News Hosted on Acast. See acast.com/privacy for more information.
Gretchen Kusek, PhD, Associate Director Scientific Services, and Bart Smits, PhD, Manager Genetic Sciences and Compliance, discuss the key considerations when breeding gene-edited animals using CRISPR, particularly in th
Collaborating for Filtration Success, Virtually by Genetic Engineering and Biotechnology News Hosted on Acast. See acast.com/privacy for more information.
Back to the Lab – Embracing Change by Genetic Engineering and Biotechnology News Hosted on Acast. See acast.com/privacy for more information.
Virtual Becomes Reality for Biopharma Vaccine Development by Genetic Engineering and Biotechnology News Hosted on Acast. See acast.com/privacy for more information.
Digital Tools Push Single-Use Technology Challenges to the Side by Genetic Engineering and Biotechnology News Hosted on Acast. See acast.com/privacy for more information.
The Quiet Voice of Immunotherapy That's Starting to Be Heard by Genetic Engineering and Biotechnology News Hosted on Acast. See acast.com/privacy for more information.
With regions of the world cycling through societal re-openings and shutdowns due to the ongoing coronavirus pandemic, pharma and life science companies are tasked with trying to find creative solutions that help keep pro
Detected from recent episode content. Sponsor presence is a real signal of listener purchasing power and show monetisation.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
GEN Podcasts has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
GEN Podcasts is hosted by Genetic Engineering and Biotechnology News. The show is categorised under Science (Life) and has published 70 episodes.
GEN Podcasts has published 70 episodes.
GEN Podcasts regularly covers Science, Life, Technology. It sits in the Science category, with a Life focus.
GEN Podcasts is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
GEN Podcasts hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of GEN Podcasts average 21 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates GEN Podcasts's guest bar at 82/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 2 days ago.